High-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A

Serum Amyloid A Induces CCL2 Production via Formyl Peptide Receptor-Like 1-Mediated Signaling in Human Monocytes

(2014) H. Y. Lee et al.   JOURNAL OF IMMUNOLOGY

Biomarkers of Inflammation and Thrombosis as Predictors of Near-Term Mortality in Patients with Peripheral Arterial Disease: A Cohort Study

(2013) Himabindu Vidula et al.   ANNALS OF INTERNAL MEDICINE

Serum Amyloid A Facilitates the Binding of High-Density Lipoprotein From Mice Injected With Lipopolysaccharide to Vascular Proteoglycans

(2011) Tsuyoshi Chiba et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Serum amyloid A in atherosclerosis

(2011) Victoria L. King et al.   CURRENT OPINION IN LIPIDOLOGY

The acute-phase protein serum amyloid A induces endothelial dysfunction that is inhibited by high-density lipoprotein

(2011) Paul K. Witting et al.   FREE RADICAL BIOLOGY AND MEDICINE

The Evolving Role of HDL in the Treatment of High-Risk Patients with Cardiovascular Disease

(2011) H. Bryan Brewer   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Serum Amyloid A Activates the NLRP3 Inflammasome via P2X7 Receptor and a Cathepsin B-Sensitive Pathway

(2011) K. Niemi et al.   JOURNAL OF IMMUNOLOGY

The endothelium-derived contracting factor uridine adenosine tetraphosphate induces P2Y2-mediated pro-inflammatory signaling by monocyte chemoattractant protein-1 formation

(2011) Mirjam Schuchardt et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Uremia Alters HDL Composition and Function

(2011) M. Holzer et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis

(2011) Amit V. Khera et al.   NEW ENGLAND JOURNAL OF MEDICINE

The versatility of HDL: a crucial anti-inflammatory regulator

(2010) Marcus D. Säemann et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

CD36 Is a Novel Serum Amyloid A (SAA) Receptor Mediating SAA Binding and SAA-induced Signaling in Human and Rodent Cells

(2010) Irina N. Baranova et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Myeloperoxidase and serum amyloid A contribute to impaired in vivo reverse cholesterol transport during the acute phase response but not group IIA secretory phospholipase A2

(2010) Wijtske Annema et al.   JOURNAL OF LIPID RESEARCH

Atherosclerosis in CKD: differences from the general population

(2010) Tilman B. Drüeke et al.   Nature Reviews Nephrology

SR-BI Selective Lipid Uptake

(2009) Maria C. de Beer et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

High-density lipoprotein: A potent inhibitor of inflammation

(2009) Andrew J Murphy et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

The Macrophage Cholesterol Exporter ABCA1 Functions as an Anti-inflammatory Receptor

(2009) Chongren Tang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Incentive-elicited mesolimbic activation and externalizing symptomatology in adolescents

(2009) James M. Bjork et al.   JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY

International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family

(2009) R. D. Ye et al.   PHARMACOLOGICAL REVIEWS

Serum Amyloid A, but Not C-Reactive Protein, Stimulates Vascular Proteoglycan Synthesis in a Pro-Atherogenic Manner

(2008) Patricia G. Wilson et al.   AMERICAN JOURNAL OF PATHOLOGY

HDL-Associated Lysosphingolipids Inhibit NAD(P)H Oxidase-Dependent Monocyte Chemoattractant Protein-1 Production

(2008) Markus Tölle et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

HDL Remodeling During the Acute Phase Response

(2008) Anisa Jahangiri et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

High-density lipoproteins, inflammation and oxidative stress

(2008) Fatiha Tabet et al.   CLINICAL SCIENCE

Is serum amyloid A an endogenous TLR4 agonist?

(2008) Silvana Sandri et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Atherosclerosis in Hemodialysis Patients—the Role of Microinflammation

(2008) Sebastjan Bevc et al.   RENAL FAILURE